Study to Evaluate the Safety and Efficacy of CAT-354
NCT00873860
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
357
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
OTHER:
Placebo
BIOLOGICAL:
CAT-354 150 mg
BIOLOGICAL:
CAT-354 300 mg
BIOLOGICAL:
CAT-354 600 mg
Sponsor
MedImmune LLC